Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China's National Medical Products Administration (NMPA)
Pharma
China approves 4 new drugs, including global 1st-in-class
China has granted the world's first approval for an HDAC/PI3K dual-targeted inhibitor.
Angus Liu
Jul 2, 2025 11:32am
Lilly, Innovent's mazdutide nabs first-in-class nod in China
Jun 27, 2025 11:16am
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Feb 28, 2025 8:45am
Kelun's Merck-partnered TROP2 ADC snags first nod in China
Nov 27, 2024 10:56am
Dr. Reddy's hit with ban from China's drug procurement program
Sep 3, 2024 3:56pm
Eli Lilly partner Hutchmed scraps stomach cancer filing
Aug 30, 2024 10:39am
